{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19384424", "DateCompleted": {"Year": "2009", "Month": "06", "Day": "26"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "04", "Day": "22"}], "Language": ["eng"], "ELocationID": ["e5284", "10.1371/journal.pone.0005284"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "4", "Issue": "4", "PubDate": {"Year": "2009"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.", "Pagination": {"StartPage": "e5284", "MedlinePgn": "e5284"}, "Abstract": {"AbstractText": ["Oxidative stress is an important contributor to cancer development. Consistent with that, antioxidant enzymes have been demonstrated to suppress tumorigenesis when being elevated both in vitro and in vivo, making induction of these enzymes a more potent approach for cancer prevention. Protandim, a well-defined combination of widely studied medicinal plants, has been shown to induce superoxide dismutase (SOD) and catalase activities and reduce superoxide generation and lipid peroxidation in healthy human subjects. To investigate whether Protandim can suppress tumor formation by a dietary approach, a two-stage mouse skin carcinogenesis study was performed. At the end of the study, the mice on a Protandim-containing basal diet had similar body weight compared with those on the basal diet, which indicated no overt toxicity by Protandim. After three weeks on the diets, there was a significant increase in the expression levels of SOD and catalase, in addition to the increases in SOD activities. Importantly, at the end of the carcinogenesis study, both skin tumor incidence and multiplicity were reduced in the mice on the Protandim diet by 33% and 57% respectively, compared with those on basal diet. Biochemical and histological studies revealed that the Protandim diet suppressed tumor promoter-induced oxidative stress (evidenced by reduction of protein carbonyl levels), cell proliferation (evidenced by reduction of skin hyperplasia and suppression of PKC/JNK/Jun pathway), and inflammation (evidenced by reduction of ICAM-1/VCAM-1 expression, NF-kappaB binding activity, and nuclear p65/p50 levels). Overall, induction of antioxidant enzymes by Protandim may serve as a practical and potent approach for cancer prevention."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America."}], "Identifier": [], "LastName": "Liu", "ForeName": "Jianfeng", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gu", "ForeName": "Xin", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Robbins", "ForeName": "Delira", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Guohong", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shi", "ForeName": "Runhua", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "McCord", "ForeName": "Joe M", "Initials": "JM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Yunfeng", "Initials": "Y"}], "GrantList": [{"GrantID": "R01 HL087990", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Protandim"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Blotting, Western"}, {"QualifierName": [], "DescriptorName": "Cell Transformation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Diet"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Electrophoretic Mobility Shift Assay"}, {"QualifierName": [], "DescriptorName": "Enzyme Induction"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred DBA"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Superoxide Dismutase"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Oberley LW, Buettner GR. Role of superoxide dismutase in cancer: a review. Cancer Res. 1979;39:1141\u20131149, review.", "ArticleIdList": ["217531"]}, {"Citation": "Oberley LW. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother. 2005;59:143\u2013148, review.", "ArticleIdList": ["15862707"]}, {"Citation": "Apte RN, Dotan S, Elkabets M, White MR, Reich E, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 2006;25:387\u2013408, review.", "ArticleIdList": ["17043764"]}, {"Citation": "Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60\u201369, review.", "ArticleIdList": ["PMC1716216", "17200707"]}, {"Citation": "Marks F, Furstenberger G, Muller-Decker K. Tumor promotion as a target of cancer prevention. Recent Results Cancer Res. 2007;174:37\u201347, review.", "ArticleIdList": ["17302183"]}, {"Citation": "Pries R, Nitsch S, Wollenberg B. Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther. 2006;6:1195\u20131203, review.", "ArticleIdList": ["17020454"]}, {"Citation": "Rose-John S, Schooltink H. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers. Recent Results Cancer Res. 2007;174:57\u201366, review.", "ArticleIdList": ["17302185"]}, {"Citation": "Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003;5:46\u201362, review.", "ArticleIdList": ["14596704"]}, {"Citation": "Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol. 2002;10:153\u2013169, review.", "ArticleIdList": ["12020670"]}, {"Citation": "Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J. 2007;401:1\u201311, review.", "ArticleIdList": ["17150040"]}, {"Citation": "Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24:353\u2013362, review.", "ArticleIdList": ["12663492"]}, {"Citation": "Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med. 2006;40:341\u2013347.", "ArticleIdList": ["16413416"]}, {"Citation": "Velmurugan K, Alam J, McCord JM, Pugazhenthi S. Synergistic induction of heme oxygenase-1 by the components of the dietary supplement Protandim. Free Radic Biol Med. 2009;46:430\u2013440.", "ArticleIdList": ["19056485"]}, {"Citation": "Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, et al. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982;257:7847\u20137851.", "ArticleIdList": ["7085651"]}, {"Citation": "Avila GE, Zheng X, Cui XX, Ryan AD, Hansson A, et al. Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice. J Pharmacol Exp Ther. 2005;315:170\u2013187.", "ArticleIdList": ["15976015"]}, {"Citation": "Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, et al. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Clin Cancer Res. 2006;12:3444\u20133451.", "ArticleIdList": ["16740769"]}, {"Citation": "Zhang X, Li W, Olumi AF. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Clin Cancer Res. 2007;13:7181\u20137190.", "ArticleIdList": ["18056199"]}, {"Citation": "Schaar D, Goodell L, Aisner J, Cui XX, Han ZT, et al. A phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies. Cancer Chemother Pharmacol. 2006;57:789\u2013795.", "ArticleIdList": ["16231182"]}, {"Citation": "Zhao Y, St Clair DK. Detection of the content and activity of the transcription factor AP-1 in a multistage skin carcinogenesis model. Methods Mol Biol. 2003;218:177\u2013184.", "ArticleIdList": ["12616721"]}, {"Citation": "Oberley LW, Spitz DR. Assay of superoxide dismutase activity in tumor tissue. Methods Enzymol. 1984;105:457\u2013464.", "ArticleIdList": ["6547201"]}, {"Citation": "DiDonato JA. Assaying for I kappa B kinase activity. Methods Enzymol. 2000;322:393\u2013400.", "ArticleIdList": ["10914035"]}, {"Citation": "Zhao Y, Kiningham KK, Lin SM, St. Clair DK. Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-Azacytidine: involvement of MAPK and NFkappaB pathways. Antioxid Redox Signal. 2001;3:375\u2013386.", "ArticleIdList": ["11499385"]}, {"Citation": "Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, et al. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 2001;61:6082\u20136088.", "ArticleIdList": ["11507057"]}, {"Citation": "Fujisawa H, Naito Y, Horiuchi S, Baba T, Otsuka F. The effects of interferon-beta on phorbol ester or calcium ionophore-induced intercellular adhesion molecule-I expression in epidermal carcinoma cells. J Dermatol. 1992;19:78\u201381.", "ArticleIdList": ["1352313"]}, {"Citation": "Dressler J, Bachmann L, Strejc P, Koch R, Muller E. Expression of adhesion molecules in skin wounds: diagnostic value in legal medicine. Forensic Sci Int. 2000;113:173\u2013176.", "ArticleIdList": ["10978620"]}, {"Citation": "Cataisson C, Pearson AJ, Torgerson S, Nedospasov SA, Yuspa SH. Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo. J Immunol. 2005;174:1686\u20131692.", "ArticleIdList": ["15661932"]}, {"Citation": "Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, et al. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res. 2002;16:639\u2013645.", "ArticleIdList": ["12410544"]}, {"Citation": "Soto C, Recoba R, Barron H, Alvarez C, Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol. 2003;136:205\u2013212.", "ArticleIdList": ["14659454"]}, {"Citation": "Chaurasia SS, Panda S, Kar A. Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mouse. Pharmacol Res. 2000;41:663\u2013666.", "ArticleIdList": ["10816336"]}, {"Citation": "Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK. Inhibition of tumour growth and inflammation by consumption of tea. Phytother Res. 2002:S40\u201344.", "ArticleIdList": ["11933138"]}, {"Citation": "Dikshit M, Rastogi L, Shukla R, Srimal RC. Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res. 1995;101:31\u201335.", "ArticleIdList": ["7883281"]}, {"Citation": "Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, et al. (-)-Epigallocatechin gallate induces Nrf2-mediated-antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys. 2008;476:171\u2013177.", "ArticleIdList": ["18424257"]}, {"Citation": "Jakubikova J, Sedlak J, Bod'o J, Bao Y. Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells. J Agric Food Chem. 2006;54:1656\u20131662.", "ArticleIdList": ["16506816"]}, {"Citation": "Das KC, Lewis-Molock Y, White CW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol. 1997;17:713\u2013726.", "ArticleIdList": ["9409558"]}, {"Citation": "Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659\u2013661.", "ArticleIdList": ["17942826"]}, {"Citation": "Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, et al. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005;65:3745\u20133750.", "ArticleIdList": ["15867370"]}, {"Citation": "Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, et al. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res. 1997;57:1468\u20131474.", "ArticleIdList": ["9108447"]}, {"Citation": "Ruckert R, Lindner G, Bulfone-Paus S, Paus R. High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol. 2000;143:1036\u20131039.", "ArticleIdList": ["11069516"]}, {"Citation": "Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death\u2013a new approach to cancer therapy. J Clin Invest. 2005;115:2625\u20132632. Review.", "ArticleIdList": ["PMC1236696", "16200195"]}, {"Citation": "Isra\u00ebl A. Signal transduction: A regulator branches out. Nature. 2003;423:596\u2013597.", "ArticleIdList": ["12789323"]}, {"Citation": "Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov. 2009;8:33\u201340. Review.", "ArticleIdList": ["PMC2729321", "19116625"]}, {"Citation": "Nakanishi C, Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer. 2005;5:297\u2013309.", "ArticleIdList": ["15803156"]}, {"Citation": "Bauer JA, Lupica JA, Schmidt H, Morrison BH, Haney RM, et al. Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling. PLoS ONE. 2007;2:e1313.", "ArticleIdList": ["PMC2117345", "18074035"]}, {"Citation": "Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12:305\u2013317, review.", "ArticleIdList": ["15898709"]}, {"Citation": "Gazak R, Walterova D, Kren V. Silybin and silymarin\u2013new and emerging applications in medicine. Curr Med Chem. 2007;14:315\u2013338, review.", "ArticleIdList": ["17305535"]}, {"Citation": "Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci. 2003;74:125\u2013132.", "ArticleIdList": ["14575818"]}, {"Citation": "Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis. 2004;7:115\u2013122.", "ArticleIdList": ["15516832"]}, {"Citation": "Clark J, You M. Chemoprevention of lung cancer by tea. Mol Nutr Food Res. 2006;50:144\u2013151, review.", "ArticleIdList": ["16425282"]}, {"Citation": "Fujiki H. Green tea: Health benefits as cancer preventive for humans. Chem Rec. 2005;5:119\u2013132, review.", "ArticleIdList": ["15889414"]}, {"Citation": "Hoshiyama Y, Kawaguchi T, Miura Y, Mizoue T, Tokui N, et al. JACC Study Group. Green tea and stomach cancer\u2013a short review of prospective studies. J Epidemiol. 2005;(Suppl 2):S109\u2013112, review.", "ArticleIdList": ["16127221"]}, {"Citation": "Stuart EC, Scandlyn MJ, Rosengren RJ. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 2006;79:2329\u20132336, review.", "ArticleIdList": ["16945390"]}, {"Citation": "Wright TI, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol. 2006;54:933\u2013946, review.", "ArticleIdList": ["16713450"]}, {"Citation": "Narayanan BA. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets. 2006;6:711\u2013727, review.", "ArticleIdList": ["17168675"]}, {"Citation": "Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41:1955\u20131968, review.", "ArticleIdList": ["16081279"]}, {"Citation": "Singh RP, Agarwal R. Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr Relat Cancer. 2006;13:751\u2013778, review.", "ArticleIdList": ["16954429"]}, {"Citation": "Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem. 2006;6:259\u2013270, review.", "ArticleIdList": ["16712454"]}]}], "History": [{"Year": "2009", "Month": "2", "Day": "11"}, {"Year": "2009", "Month": "3", "Day": "20"}, {"Year": "2009", "Month": "4", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "4", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "6", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "4", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19384424", "PMC2668769", "10.1371/journal.pone.0005284"]}}], "PubmedBookArticle": []}